This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Investigation

Authoring team

The salient investigations in chronic pancreatitis include:

  • blood tests:
    • serum amylase - usually normal but may be mildly raised in an acute on chronic attack
    • albumin and clotting studies - may be abnormal due to associated cirrhosis or malabsorption
    • low calcium or serum vitamin B12 suggests malabsorption
    • elevated alkaline phosphatase suggests biliary tract obstruction if gamma GT is raised, or rarely, osteomalacia
    • glucose may be raised if exocrine insufficiency

  • imaging:
    • abdominal x-ray - 30% show pancreatic calcification in later stages
    • ultrasound - reveals gallstones, duct dilatation, pancreatic morphology
    • CT scan - indicated if ultrasound is abnormal; shows major abnormalities in pancreatic anatomy
      • computed tomography is the first-line imaging modality for people with a history and symptoms suggestive of chronic alcohol-related pancreatitis (1)
    • ERCP - "gold standard"; reveals duct dilatation and distortion of main pancreatic duct and side branches; however, a normal ERCP does not absolutely exclude chronic pancreatitis

  • functional tests - e.g. secretin, Lundh, pancreolauryl tests - useful in the diagnosis of patients who have recurrent symptoms and whose imaging and other tests are normal
  • tests of pancreatic exocrine and endocrine function











Reference:

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.